Cargando…
Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial
ABSTRACT: Lynch syndrome (LS) is the most common cause of inherited colorectal cancer (CRC) and confers a high lifetime risk of CRC estimated to be up to 60%. Colonoscopy is recommended every 2 years in LS patients above the 20–25-year-old age bracket, and every year when colonic neoplasia has been...
Autores principales: | Soualy, Adil, Deutsch, David, Benallaoua, Mourad, Ait-Omar, Amal, Mary, Florence, Helfen, Sabine, Boubaya, Marouane, Levy, Vincent, Benamouzig, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487877/ https://www.ncbi.nlm.nih.gov/pubmed/32887653 http://dx.doi.org/10.1186/s13063-020-04674-8 |
Ejemplares similares
-
Pyloric Gland Adenoma in Lynch Syndrome
por: Lee, Seung Eun, et al.
Publicado: (2014) -
Multiple colorectal adenomas in Lynch syndrome
por: Jain, Ayushi, et al.
Publicado: (2022) -
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
por: Reyes-Uribe, Laura, et al.
Publicado: (2021) -
Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome
por: Beck,, Sarah Leilani
Publicado: (2012) -
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
por: Vleugels, Jasper L.A., et al.
Publicado: (2019)